BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35237005)

  • 1. Cystic Intracranial Recurrence of Olfactory Neuroblastoma without Accumulation on Fluorine-18-fluorodeoxyglucose Positron Emission Tomography.
    Ishi Y; Yamaguchi S; Hatanaka KC; Takakuwa E; Motegi H; Honda T; Kobayashi H; Terasaka S; Homma A; Fujimura M; Houkin K
    Acta Med Okayama; 2022 Feb; 76(1):93-98. PubMed ID: 35237005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of olfactory neuroblastoma detected by (18)F-FDG PET/CT.
    Tanaka K; Yamamoto Y; Hoshikawa H; Nishiyama Y
    Clin Nucl Med; 2014 Jul; 39(7):635-6. PubMed ID: 24662664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up using 18F-FDG PET/CT for postoperative olfactory neuroblastoma.
    Fujioka T; Toriihara A; Kubota K; Machida Y; Nakamura S; Kishimoto S; Ohashi I; Shibuya H
    Nucl Med Commun; 2014 Aug; 35(8):857-63. PubMed ID: 24751700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Olfactory Neuroblastoma in Remote Leptomeninges, Mimicking Intracranial Meningioma.
    Kim YS; Jung S; Jang WY; Lee KH; Moon KS; Kim IY
    World Neurosurg; 2016 Dec; 96():612.e9-612.e14. PubMed ID: 27609444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary study on the evaluation of olfactory neuroblastoma using PET/CT.
    Wu HB; Wang QS; Zhong JM; Zhou WL; Li HS; Qiao-yu W
    Clin Nucl Med; 2011 Oct; 36(10):894-8. PubMed ID: 21892040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma.
    Broski SM; Hunt CH; Johnson GB; Subramaniam RM; Peller PJ
    J Nucl Med; 2012 Aug; 53(8):1200-6. PubMed ID: 22728262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esthesioneuroblastoma: one of the causes of proptosis.
    Ansari S; Ahmad K; Dhungel K; Gupta MK; Amanullah MF
    Head Face Med; 2013 Jul; 9():19. PubMed ID: 23890074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory neuroblastoma behavior inside and outside the olfactory cleft.
    Jankowski R; Russel A; Gallet P; Henrot P; Vignaud JM; Nguyen DT
    Surg Radiol Anat; 2015 Jul; 37(5):507-15. PubMed ID: 25218517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High 18F-FDG Avidity of Low-Grade Esthesioneuroblastoma.
    Jannin A; Turpin A; Baillet C; Aubert S; Do Cao C
    Clin Nucl Med; 2018 Mar; 43(3):e101-e102. PubMed ID: 29293141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary olfactory neuroblastoma originating from the inferior meatus of the nasal cavity.
    Lee JY; Kim HK
    Am J Otolaryngol; 2007; 28(3):196-200. PubMed ID: 17499140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory neuroblastoma presenting as bleeding polyp.
    Niazi SA; Saeedullah
    J Ayub Med Coll Abbottabad; 2012; 24(3-4):208-9. PubMed ID: 24669656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga-DOTATATE and 18F-FDG PET/CT for the Management of Esthesioneuroblastoma of the Sphenoclival Region.
    Dadgar H; Norouzbeigi N; Ahmadzadehfar H; Assadi M
    Clin Nucl Med; 2020 Aug; 45(8):e363-e364. PubMed ID: 32558717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed Tomography Image Analysis and Clinical Diagnosis Value of Nasal Olfactory Neuroblastoma.
    Zhang S; Li Q; Zhang F; Xu H; Gao H
    World Neurosurg; 2021 May; 149():333-340. PubMed ID: 33039569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Olfactory neuroblastoma in an old patient. Report of a case].
    Pino Rivero V; Trinidad Ruíz G; González Palomino A; Pardo Romero G; Pantoja Hernández CG; Marcos García M; Montero García C; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2005; 32(5):429-35. PubMed ID: 16318085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory neuroblastoma and olfactory ventricle. A case report.
    Pozzati E; Martinoni M; Marucci G; Bacci A
    Neuroradiol J; 2014 Sep; 27(4):452-5. PubMed ID: 25196619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndrome of inappropriate antidiuretic hormone secretion in a case of olfactory neuroblastoma without anti-diuretic hormone immunoreactivity: A case report and review of the literature.
    Nakano T; Motoshita J; Sawada F; Okabe M; Tamae A; Hiramatsu S; Kodama S; Shiratsuchi H; Yasumatsu R; Nakashima T; Nakagawa T
    Auris Nasus Larynx; 2017 Dec; 44(6):771-774. PubMed ID: 28010942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of
    Elkhatib AH; Soldatova L; Carrau RL; Hachem RA; Ditzel L; Campbell R; Prevedello DM; Prevedello L; Filho LF; Campbell RG
    Laryngoscope; 2017 Feb; 127(2):321-324. PubMed ID: 27481043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 FDG PET/CT staging and posttherapeutic assessment of esthesioneuroblastoma.
    Nguyen BD; Roarke MC; Nelson KD; Chong BW
    Clin Nucl Med; 2006 Mar; 31(3):172-4. PubMed ID: 16495744
    [No Abstract]   [Full Text] [Related]  

  • 19. Remote orbital recurrence of olfactory neuroblastoma (esthesioneuroblastoma).
    Breazzano MP; Lewis JS; Chambless LB; Rohde SL; Sobel RK
    Orbit; 2017 Aug; 36(4):247-250. PubMed ID: 28362545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esthesioneuroblastoma on 68Ga DOTANOC PET/CT.
    Tripathy S; Kumar R; Kakkar A; Kumar R; Sharma P; Shamim SA
    Clin Nucl Med; 2019 Aug; 44(8):e486-e488. PubMed ID: 31274630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.